Topic: Relmada Therapeutics

Relmada Therapeutics has a total of 72 patents globally, out of which 25 have been granted. Of these 72 patents, more than 34% patents are active. The United States of America is where Relmada Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, United